logo

For the Inventor, By the Inventor

Hannou, Japan

Kenji Nozaki

This inventor holds 5 USPTO granted patents. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 1993-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Nozaki. Retrieved from https://idiyas.com/inventor/kenji-nozaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Hanno, JP (1995 - 1998)
  • Hannou, JP (1993 - 2004)

Company Filing History:

goldMedal5 out of 320 
 
Taiho Pharmaceutical Company Limited
 patents

Years Active: 1993-2004

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6717002 - Method of producing steroid derivatives (2004-04-06),
2. 5786355 - 4,6-diarylpyrimidine derivatives and salts thereof (1998-07-28),
3. 5399577 - Isoxazole derivatives and salts thereof (1995-03-21),
4. 5318970 - Isoxazole compounds, pharmaceutically acceptable salts thereof and (1994-06-07),
5. 5182284 - Piperazine compounds, processes for preparation thereof and medical uses (1993-01-26),

Title: Kenji Nozaki: Innovator in Pharmaceutical Chemistry

Introduction

Kenji Nozaki is a prominent inventor based in Hannou, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of steroid derivatives. With a total of 5 patents to his name, Nozaki has established himself as a key figure in his industry.

Latest Patents

Among his latest patents is a method of producing steroid derivatives, which showcases his innovative approach to pharmaceutical development. Additionally, he has worked on the creation of 4,6-diarylpyrimidine derivatives and their salts, further expanding the scope of his research and contributions.

Career Highlights

Nozaki is currently employed at Taiho Pharmaceutical Company Limited, where he continues to push the boundaries of pharmaceutical innovation. His work has not only advanced the field but has also contributed to the development of new therapeutic options.

Collaborations

Throughout his career, Nozaki has collaborated with notable colleagues, including Masahiro Suzuki and Naohiko Ono. These partnerships have enriched his research and have led to significant advancements in their shared field.

Conclusion

Kenji Nozaki's contributions to pharmaceutical chemistry are noteworthy, and his innovative spirit continues to drive advancements in the industry. His work exemplifies the impact of dedicated inventors in the realm of science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…